 | • レポートコード：MRC2-11QY03043 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はベーチェット病治療薬のグローバル市場について調査・分析したレポートです。種類別（アダリムマブバイオシミラー、アプレミラスト、カナキヌマブ、インフリキシマブバイオシミラー、その他）市場規模、用途別（在宅介護、病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ベーチェット病治療薬の競争状況、市場シェア ・世界のベーチェット病治療薬市場：種類別市場規模 2015年-2020年（アダリムマブバイオシミラー、アプレミラスト、カナキヌマブ、インフリキシマブバイオシミラー、その他） ・世界のベーチェット病治療薬市場：種類別市場規模予測 2021年-2026年（アダリムマブバイオシミラー、アプレミラスト、カナキヌマブ、インフリキシマブバイオシミラー、その他） ・世界のベーチェット病治療薬市場：用途別市場規模 2015年-2020年（在宅介護、病院、クリニック） ・世界のベーチェット病治療薬市場：用途別市場規模予測 2021年-2026年（在宅介護、病院、クリニック） ・北米のベーチェット病治療薬市場分析：米国、カナダ ・ヨーロッパのベーチェット病治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのベーチェット病治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のベーチェット病治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのベーチェット病治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie Inc、Celgene Corp、Cell Medica Ltd、Coherus BioSciences Inc、Genor BioPharma Co Ltd、Novartis AG、Panacea Biotec Ltd、R Pharm ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Behcet Disease Drug Market
The global Behcet Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Behcet Disease Drug Scope and Market Size
Behcet Disease Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Behcet Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Behcet Disease Drug market is segmented into
Adalimumab Biosimilar
Apremilast
Canakinumab
Infliximab Biosimilar
Others
Segment by Application, the Behcet Disease Drug market is segmented into
Home Care
Hospital
Clinic
Regional and Country-level Analysis
The Behcet Disease Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Behcet Disease Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Behcet Disease Drug Market Share Analysis
Behcet Disease Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Behcet Disease Drug business, the date to enter into the Behcet Disease Drug market, Behcet Disease Drug product introduction, recent developments, etc.
The major vendors covered:
AbbVie Inc
Celgene Corp
Cell Medica Ltd
Coherus BioSciences Inc
Genor BioPharma Co Ltd
Novartis AG
Panacea Biotec Ltd
R Pharm
1 Study Coverage
1.1 Behcet Disease Drug Product Introduction
1.2 Market Segments
1.3 Key Behcet Disease Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Behcet Disease Drug Market Size Growth Rate by Type
1.4.2 Adalimumab Biosimilar
1.4.3 Apremilast
1.4.4 Canakinumab
1.4.5 Infliximab Biosimilar
1.4.6 Others
1.5 Market by Application
1.5.1 Global Behcet Disease Drug Market Size Growth Rate by Application
1.5.2 Home Care
1.5.3 Hospital
1.5.4 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Behcet Disease Drug Market Size, Estimates and Forecasts
2.1.1 Global Behcet Disease Drug Revenue 2015-2026
2.1.2 Global Behcet Disease Drug Sales 2015-2026
2.2 Global Behcet Disease Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Behcet Disease Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Behcet Disease Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Behcet Disease Drug Competitor Landscape by Players
3.1 Behcet Disease Drug Sales by Manufacturers
3.1.1 Behcet Disease Drug Sales by Manufacturers (2015-2020)
3.1.2 Behcet Disease Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Behcet Disease Drug Revenue by Manufacturers
3.2.1 Behcet Disease Drug Revenue by Manufacturers (2015-2020)
3.2.2 Behcet Disease Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Behcet Disease Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Behcet Disease Drug Revenue in 2019
3.2.5 Global Behcet Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Behcet Disease Drug Price by Manufacturers
3.4 Behcet Disease Drug Manufacturing Base Distribution, Product Types
3.4.1 Behcet Disease Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Behcet Disease Drug Product Type
3.4.3 Date of International Manufacturers Enter into Behcet Disease Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Behcet Disease Drug Market Size by Type (2015-2020)
4.1.1 Global Behcet Disease Drug Sales by Type (2015-2020)
4.1.2 Global Behcet Disease Drug Revenue by Type (2015-2020)
4.1.3 Behcet Disease Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Behcet Disease Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Behcet Disease Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Behcet Disease Drug Revenue Forecast by Type (2021-2026)
4.2.3 Behcet Disease Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Behcet Disease Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Behcet Disease Drug Market Size by Application (2015-2020)
5.1.1 Global Behcet Disease Drug Sales by Application (2015-2020)
5.1.2 Global Behcet Disease Drug Revenue by Application (2015-2020)
5.1.3 Behcet Disease Drug Price by Application (2015-2020)
5.2 Behcet Disease Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Behcet Disease Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Behcet Disease Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Behcet Disease Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Behcet Disease Drug by Country
6.1.1 North America Behcet Disease Drug Sales by Country
6.1.2 North America Behcet Disease Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Behcet Disease Drug Market Facts & Figures by Type
6.3 North America Behcet Disease Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Behcet Disease Drug by Country
7.1.1 Europe Behcet Disease Drug Sales by Country
7.1.2 Europe Behcet Disease Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Behcet Disease Drug Market Facts & Figures by Type
7.3 Europe Behcet Disease Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Behcet Disease Drug by Region
8.1.1 Asia Pacific Behcet Disease Drug Sales by Region
8.1.2 Asia Pacific Behcet Disease Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Behcet Disease Drug Market Facts & Figures by Type
8.3 Asia Pacific Behcet Disease Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Behcet Disease Drug by Country
9.1.1 Latin America Behcet Disease Drug Sales by Country
9.1.2 Latin America Behcet Disease Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Behcet Disease Drug Market Facts & Figures by Type
9.3 Central & South America Behcet Disease Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Behcet Disease Drug by Country
10.1.1 Middle East and Africa Behcet Disease Drug Sales by Country
10.1.2 Middle East and Africa Behcet Disease Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Behcet Disease Drug Market Facts & Figures by Type
10.3 Middle East and Africa Behcet Disease Drug Market Facts & Figures by Application
11 Company Profiles
11.1 AbbVie Inc
11.1.1 AbbVie Inc Corporation Information
11.1.2 AbbVie Inc Description and Business Overview
11.1.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Inc Behcet Disease Drug Products Offered
11.1.5 AbbVie Inc Related Developments
11.2 Celgene Corp
11.2.1 Celgene Corp Corporation Information
11.2.2 Celgene Corp Description and Business Overview
11.2.3 Celgene Corp Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Celgene Corp Behcet Disease Drug Products Offered
11.2.5 Celgene Corp Related Developments
11.3 Cell Medica Ltd
11.3.1 Cell Medica Ltd Corporation Information
11.3.2 Cell Medica Ltd Description and Business Overview
11.3.3 Cell Medica Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Cell Medica Ltd Behcet Disease Drug Products Offered
11.3.5 Cell Medica Ltd Related Developments
11.4 Coherus BioSciences Inc
11.4.1 Coherus BioSciences Inc Corporation Information
11.4.2 Coherus BioSciences Inc Description and Business Overview
11.4.3 Coherus BioSciences Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Coherus BioSciences Inc Behcet Disease Drug Products Offered
11.4.5 Coherus BioSciences Inc Related Developments
11.5 Genor BioPharma Co Ltd
11.5.1 Genor BioPharma Co Ltd Corporation Information
11.5.2 Genor BioPharma Co Ltd Description and Business Overview
11.5.3 Genor BioPharma Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Genor BioPharma Co Ltd Behcet Disease Drug Products Offered
11.5.5 Genor BioPharma Co Ltd Related Developments
11.6 Novartis AG
11.6.1 Novartis AG Corporation Information
11.6.2 Novartis AG Description and Business Overview
11.6.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novartis AG Behcet Disease Drug Products Offered
11.6.5 Novartis AG Related Developments
11.7 Panacea Biotec Ltd
11.7.1 Panacea Biotec Ltd Corporation Information
11.7.2 Panacea Biotec Ltd Description and Business Overview
11.7.3 Panacea Biotec Ltd Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Panacea Biotec Ltd Behcet Disease Drug Products Offered
11.7.5 Panacea Biotec Ltd Related Developments
11.8 R Pharm
11.8.1 R Pharm Corporation Information
11.8.2 R Pharm Description and Business Overview
11.8.3 R Pharm Sales, Revenue and Gross Margin (2015-2020)
11.8.4 R Pharm Behcet Disease Drug Products Offered
11.8.5 R Pharm Related Developments
11.1 AbbVie Inc
11.1.1 AbbVie Inc Corporation Information
11.1.2 AbbVie Inc Description and Business Overview
11.1.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Inc Behcet Disease Drug Products Offered
11.1.5 AbbVie Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Behcet Disease Drug Market Estimates and Projections by Region
12.1.1 Global Behcet Disease Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Behcet Disease Drug Revenue Forecast by Regions 2021-2026
12.2 North America Behcet Disease Drug Market Size Forecast (2021-2026)
12.2.1 North America: Behcet Disease Drug Sales Forecast (2021-2026)
12.2.2 North America: Behcet Disease Drug Revenue Forecast (2021-2026)
12.2.3 North America: Behcet Disease Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Behcet Disease Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Behcet Disease Drug Sales Forecast (2021-2026)
12.3.2 Europe: Behcet Disease Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Behcet Disease Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Behcet Disease Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Behcet Disease Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Behcet Disease Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Behcet Disease Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Behcet Disease Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Behcet Disease Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Behcet Disease Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Behcet Disease Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Behcet Disease Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Behcet Disease Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Behcet Disease Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Behcet Disease Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Behcet Disease Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Behcet Disease Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Behcet Disease Drug Market Segments
Table 2. Ranking of Global Top Behcet Disease Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Behcet Disease Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Adalimumab Biosimilar
Table 5. Major Manufacturers of Apremilast
Table 6. Major Manufacturers of Canakinumab
Table 7. Major Manufacturers of Infliximab Biosimilar
Table 8. Major Manufacturers of Others
Table 9. Global Behcet Disease Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Behcet Disease Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Behcet Disease Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Behcet Disease Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Behcet Disease Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Behcet Disease Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Behcet Disease Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Behcet Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Behcet Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Behcet Disease Drug as of 2019)
Table 18. Behcet Disease Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Behcet Disease Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Behcet Disease Drug Price (2015-2020) (USD/Pcs)
Table 21. Behcet Disease Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Behcet Disease Drug Product Type
Table 23. Date of International Manufacturers Enter into Behcet Disease Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Behcet Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Behcet Disease Drug Sales Share by Type (2015-2020)
Table 27. Global Behcet Disease Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Behcet Disease Drug Revenue Share by Type (2015-2020)
Table 29. Behcet Disease Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Behcet Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Behcet Disease Drug Sales Share by Application (2015-2020)
Table 32. North America Behcet Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Behcet Disease Drug Sales Market Share by Country (2015-2020)
Table 34. North America Behcet Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Behcet Disease Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Behcet Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Behcet Disease Drug Sales Market Share by Type (2015-2020)
Table 38. North America Behcet Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Behcet Disease Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Behcet Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Behcet Disease Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Behcet Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Behcet Disease Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Behcet Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Behcet Disease Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Behcet Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Behcet Disease Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Behcet Disease Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Behcet Disease Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Behcet Disease Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Behcet Disease Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Behcet Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Behcet Disease Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Behcet Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Behcet Disease Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Behcet Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Behcet Disease Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Behcet Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Behcet Disease Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Behcet Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Behcet Disease Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Behcet Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Behcet Disease Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Behcet Disease Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Behcet Disease Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Behcet Disease Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Behcet Disease Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Behcet Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Behcet Disease Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Behcet Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Behcet Disease Drug Sales Market Share by Application (2015-2020)
Table 72. AbbVie Inc Corporation Information
Table 73. AbbVie Inc Description and Major Businesses
Table 74. AbbVie Inc Behcet Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. AbbVie Inc Product
Table 76. AbbVie Inc Recent Development
Table 77. Celgene Corp Corporation Information
Table 78. Celgene Corp Description and Major Businesses
Table 79. Celgene Corp Behcet Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Celgene Corp Product
Table 81. Celgene Corp Recent Development
Table 82. Cell Medica Ltd Corporation Information
Table 83. Cell Medica Ltd Description and Major Businesses
Table 84. Cell Medica Ltd Behcet Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Cell Medica Ltd Product
Table 86. Cell Medica Ltd Recent Development
Table 87. Coherus BioSciences Inc Corporation Information
Table 88. Coherus BioSciences Inc Description and Major Businesses
Table 89. Coherus BioSciences Inc Behcet Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Coherus BioSciences Inc Product
Table 91. Coherus BioSciences Inc Recent Development
Table 92. Genor BioPharma Co Ltd Corporation Information
Table 93. Genor BioPharma Co Ltd Description and Major Businesses
Table 94. Genor BioPharma Co Ltd Behcet Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Genor BioPharma Co Ltd Product
Table 96. Genor BioPharma Co Ltd Recent Development
Table 97. Novartis AG Corporation Information
Table 98. Novartis AG Description and Major Businesses
Table 99. Novartis AG Behcet Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Novartis AG Product
Table 101. Novartis AG Recent Development
Table 102. Panacea Biotec Ltd Corporation Information
Table 103. Panacea Biotec Ltd Description and Major Businesses
Table 104. Panacea Biotec Ltd Behcet Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Panacea Biotec Ltd Product
Table 106. Panacea Biotec Ltd Recent Development
Table 107. R Pharm Corporation Information
Table 108. R Pharm Description and Major Businesses
Table 109. R Pharm Behcet Disease Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. R Pharm Product
Table 111. R Pharm Recent Development
Table 112. Global Behcet Disease Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 113. Global Behcet Disease Drug Sales Market Share Forecast by Regions (2021-2026)
Table 114. Global Behcet Disease Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 115. Global Behcet Disease Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 116. North America: Behcet Disease Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 117. North America: Behcet Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Europe: Behcet Disease Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 119. Europe: Behcet Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Asia Pacific: Behcet Disease Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 121. Asia Pacific: Behcet Disease Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 122. Latin America: Behcet Disease Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 123. Latin America: Behcet Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Middle East and Africa: Behcet Disease Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 125. Middle East and Africa: Behcet Disease Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 127. Key Challenges
Table 128. Market Risks
Table 129. Main Points Interviewed from Key Behcet Disease Drug Players
Table 130. Behcet Disease Drug Customers List
Table 131. Behcet Disease Drug Distributors List
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Behcet Disease Drug Product Picture
Figure 2. Global Behcet Disease Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Adalimumab Biosimilar Product Picture
Figure 4. Apremilast Product Picture
Figure 5. Canakinumab Product Picture
Figure 6. Infliximab Biosimilar Product Picture
Figure 7. Others Product Picture
Figure 8. Global Behcet Disease Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Home Care
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Behcet Disease Drug Report Years Considered
Figure 13. Global Behcet Disease Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Behcet Disease Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Behcet Disease Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Behcet Disease Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Behcet Disease Drug Sales Market Share by Region in 2019
Figure 18. Global Behcet Disease Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Behcet Disease Drug Revenue Market Share by Region in 2019
Figure 20. Global Behcet Disease Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Behcet Disease Drug Revenue in 2019
Figure 22. Behcet Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Behcet Disease Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Behcet Disease Drug Sales Market Share by Type in 2019
Figure 25. Global Behcet Disease Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Behcet Disease Drug Revenue Market Share by Type in 2019
Figure 27. Global Behcet Disease Drug Market Share by Price Range (2015-2020)
Figure 28. Global Behcet Disease Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Behcet Disease Drug Sales Market Share by Application in 2019
Figure 30. Global Behcet Disease Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Behcet Disease Drug Revenue Market Share by Application in 2019
Figure 32. North America Behcet Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Behcet Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Behcet Disease Drug Sales Market Share by Country in 2019
Figure 35. North America Behcet Disease Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Behcet Disease Drug Market Share by Type in 2019
Figure 41. North America Behcet Disease Drug Market Share by Application in 2019
Figure 42. Europe Behcet Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Behcet Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Behcet Disease Drug Sales Market Share by Country in 2019
Figure 45. Europe Behcet Disease Drug Revenue Market Share by Country in 2019
Figure 46. Germany Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Behcet Disease Drug Market Share by Type in 2019
Figure 57. Europe Behcet Disease Drug Market Share by Application in 2019
Figure 58. Asia Pacific Behcet Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Behcet Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Behcet Disease Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Behcet Disease Drug Revenue Market Share by Region in 2019
Figure 62. China Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Behcet Disease Drug Market Share by Type in 2019
Figure 85. Asia Pacific Behcet Disease Drug Market Share by Application in 2019
Figure 86. Latin America Behcet Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Behcet Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Behcet Disease Drug Sales Market Share by Country in 2019
Figure 89. Latin America Behcet Disease Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Behcet Disease Drug Market Share by Type in 2019
Figure 97. Latin America Behcet Disease Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Behcet Disease Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Behcet Disease Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Behcet Disease Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Behcet Disease Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Behcet Disease Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Behcet Disease Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Behcet Disease Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Behcet Disease Drug Market Share by Application in 2019
Figure 110. North America Behcet Disease Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Behcet Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Behcet Disease Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Behcet Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Behcet Disease Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Behcet Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Behcet Disease Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Behcet Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Behcet Disease Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Behcet Disease Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
ベーチェット病治療の世界市場（～2026年） Behcet disease, also called Behcet's syndrome, is a rare disorder that causes blood vessel inflammation throughout your body. Market Analysis and Insights: Global Behcet Disease Treatment Market The global Behcet Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX…- クローン病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Crohn’s Disease Drug Market The global Crohn’s Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Crohn’s Disease Drug Scope and Market Size Crohn’s Disease Drug market is…
- シャルコー・マリー・トゥース病IA型治療薬の世界市場（～2026年） Market Analysis and Insights: Global Charcot-Marie-Tooth Disease Type I A Drug Market The global Charcot-Marie-Tooth Disease Type I A Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Charcot-Marie-Tooth Disease Typ…
- シャーガス病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chagas Disease Drug Market The global Chagas Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chagas Disease Drug Scope and Market Size Chagas Disease Drug market is seg…
- 性感染症（STD）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Sexually Transmitted Disease (STD ) Drug Market The global Sexually Transmitted Disease (STD ) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Sexually Transmitted Disease (STD…